CTBP1 and temporal lobe epilepsy: In another study, the glycolytic inhibitor, 2-deoxy-D-glucose, suppressed seizure activity in a model of temporal lobe epilepsy via an NRSF/CtBP-dependent repression of the brain-derived neurotrophic factor gene promoter [48].